BRIEF-Aspen Pharmacare says hasn't raised prices outside regulatory framework
May 30 Aspen Pharmacare Holdings Ltd:
* Further confirms pharmaceutical prices are approved by department of health in terms of single exit price regulatory framework
* Aspen had not increased pricing of its products outside of this regulatory framework
* "Democratic Alliance is satisfied that there is no evidence that Aspen is involved in same practices that they are accused of having pursued in Europe?